{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T09:43:41Z","timestamp":1749721421212,"version":"3.41.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1997,2,1]],"date-time":"1997-02-01T00:00:00Z","timestamp":854755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1997,2,1]],"date-time":"1997-02-01T00:00:00Z","timestamp":854755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[1997,2]]},"DOI":"10.1023\/a:1027359422433","type":"journal-article","created":{"date-parts":[[2003,11,9]],"date-time":"2003-11-09T22:46:39Z","timestamp":1068417999000},"page":"151-162","source":"Crossref","is-referenced-by-count":19,"title":["Clozapine and Some Other Antipsychotic Drugs May Preferentially Block the Same Subset of GABAA Receptors"],"prefix":"10.1007","volume":"22","author":[{"given":"Richard F.","family":"Squires","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Else","family":"Saederup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"425674_CR1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/BF00966587","volume":"16","author":"R. F. Squires","year":"1991","unstructured":"Squires, R. F., and Saederup, E. 1991. A review of evidence for GABergic predominance\/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of \u201cfunctional\u201d psychosis. Neurochem. Res. 16:1099\u20131111.","journal-title":"Neurochem. Res."},{"key":"425674_CR2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/335076a0","volume":"335","author":"E. S. Levitan","year":"1988","unstructured":"Levitan, E. S., Schofield, P. R., Burt, D. R., Rhee, L. M., Wisden, W., K\u00f6hler, M., Fujita, N., Rodriguez, H. F., Stephenson, A., Darlison, M. G., Barnard, E. A., and Seeburg, P. H. 1988. Structural and functional basis for GABAA receptor heterogeneity. Nature 335:76\u201379.","journal-title":"Nature"},{"key":"425674_CR3","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1523\/JNEUROSCI.12-03-01040.1992","volume":"12","author":"W. Wisden","year":"1992","unstructured":"Wisden, W., Laurie, D. J., Monyer, H., and Seeburg, P. H. 1992. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, Diencephalon, Mesencephalon. J. Neurosci. 12:1040\u20131062.","journal-title":"J. Neurosci."},{"key":"425674_CR4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/338582a0","volume":"338","author":"D. B. Pritchett","year":"1989","unstructured":"Pritchett, D. B., Sontheimer, H., Shivers, B. D., Ymer, S., Kettenmann, H., Schofield, P. R., and Seeburg, P. H. 1989. Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature 338:582\u2013585.","journal-title":"Nature"},{"key":"425674_CR5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.2551039","volume":"245","author":"D. B. Pritchett","year":"1989","unstructured":"Pritchett, D. B., L\u00fcddens, H., and Seeburg, P. H. 1989. Type I and Type II GABAA-benzodiazepine receptors produced in transfected cells. Science 245:1389\u20131392.","journal-title":"Science"},{"key":"425674_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0896-6273(89)90257-2","volume":"3","author":"B. D. Shivers","year":"1989","unstructured":"Shivers, B. D., Killisch, I., Sprengel, R., Sontheimer, H., K\u00f6hler, M., Schofield, P. R., and Seeburg, P. H. 1989. Two novel GABAA receptor subunits exist in distinct neuronal subpopulations. Neuron 3:327\u2013337.","journal-title":"Neuron"},{"key":"425674_CR7","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1073\/pnas.92.17.7749","volume":"92","author":"U. G\u00fcnther","year":"1995","unstructured":"G\u00fcnther, U., Benson, J., Benke, D., Fritschy, J.-M., Reyes, G., Knoflach, F., Crestani, F., Aguzzi, A., Arigoni, M., Lang, Y., Bluethmann, H., Mohler, H., and L\u00fcscher, B. 1995. Benzodiazepine-insensitive mice generated by targeted disruption of the \u03b32 subunit gene of \u03b3-aminobutyric acid type A receptors. Proc. Nat. Acad. Sci. 92:7749\u20137753.","journal-title":"Proc. Nat. Acad. Sci."},{"key":"425674_CR8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0091-3057(79)90341-1","volume":"10","author":"R. F. Squires","year":"1979","unstructured":"Squires, R. F., Benson, D. I., Braestrup, C., Coupet, J., Klepner, C. A., Myers, V., and Beer, B. 1979. Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors. Pharmacol. Biochem. Behav. 10:825\u2013830.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"425674_CR9","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0028-3908(83)90112-0","volume":"22","author":"R. F. Squires","year":"1983","unstructured":"Squires, R. F. 1983. Benzodiazepine receptor multiplicity. Neuropharmacology 22:1443\u20131450.","journal-title":"Neuropharmacology"},{"key":"425674_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-2236(96)80023-3","volume":"19","author":"R. M. McKernan","year":"1996","unstructured":"McKernan, R. M., and Whiting, P. J. 1996. Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci. 19:139\u2013143.","journal-title":"Trends Neurosci."},{"key":"425674_CR11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cne.903590111","volume":"359","author":"J.-M. Fritschy","year":"1995","unstructured":"Fritschy, J.-M., and Mohler, H. 1995. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359:154\u2013194.","journal-title":"J. Comp. Neurol."},{"key":"425674_CR12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/314168a0","volume":"314","author":"P. Schoch","year":"1985","unstructured":"Schoch, P., Richards, J. G., H\u00e4ring, P., Takacs, B., St\u00e4hli, C., Staehelin, T., Haefely, W., and M\u00f6hler, H. 1985. Co-localization of GABAA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies. Nature 314:168\u2013171.","journal-title":"Nature"},{"key":"425674_CR13","first-page":"79","volume-title":"GABA and Benzodiazepine Receptors","author":"J. K. Wamsley","year":"1988","unstructured":"Wamsley, J. K., McCabe, R. T., and Gehlert, D. R. 1988. Autoradiographic localization of binding sites in several GABA and benzodiazepine receptor complexes. Pages 79\u201389, in Squires, R. F. (ed.), GABA and Benzodiazepine Receptors, Vol. I, CRC Press, Inc., Boca Raton, FL."},{"key":"425674_CR14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0026-895X(25)14273-9","volume":"23","author":"R. F. Squires","year":"1983","unstructured":"Squires, R. F., Casida, J. E., Richardson, M., and Saederup, E. 1983. [35S]t-Butylbicyclo-phosphorothionate binds with high afinity to brain-specific sites coupled to \u03b3-aminobutyric acid-A and ion recognition sites. Mol. Pharmacol. 23:326\u2013336.","journal-title":"Mol. Pharmacol."},{"key":"425674_CR15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-8993(87)90017-5","volume":"414","author":"R. F. Squires","year":"1987","unstructured":"Squires, R. F., and Saederup, E. 1987. GABAA receptor blockers reverse the inhibitory effect of GABA on brain-specific [35S]TBPS binding. Brain Res. 414:357\u2013364.","journal-title":"Brain Res."},{"key":"425674_CR16","first-page":"388","volume":"10","author":"R. F. Squires","year":"1984","unstructured":"Squires, R. F., and Saederup, E. 1984. GABA antagonists, antidepressants, central stimulants and other substances reverse the inhibitory effect of GABA on the binding of TBPS to brain specific sites. Soc. Neurosci. Abstr. 10:388.","journal-title":"Soc. Neurosci. Abstr."},{"key":"425674_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0006-8993(88)91378-9","volume":"441","author":"R. F. Squires","year":"1988","unstructured":"Squires, R. F., and Saederup, E. 1988. Antidepressants and metabolites that block GABAA receptors coupled to 15S-t-butylbi-cyclophosphorothionate binding sites in rat brain. Brain Res. 441:15\u201322.","journal-title":"Brain Res."},{"key":"425674_CR18","first-page":"1733","volume":"21","author":"R. F. Squires","year":"1995","unstructured":"Squires, R. F., and Saederup, E. 1995. Clozapine selectively blocks a subset of GABAA receptors. Soc. Neurosci. Abstr. 21:1733.","journal-title":"Soc. Neurosci. Abstr."},{"key":"425674_CR19","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1126\/science.6281892","volume":"216","author":"C. Braestrup","year":"1982","unstructured":"Braestrup, C., Schmiechen, R., Neef, G., Nielsen, M., and Petersen, E. N. 1982. Interaction of convulsive ligands with benzodiazepine receptors. Science 216:1241\u20131243.","journal-title":"Science"},{"key":"425674_CR20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/BF00966774","volume":"18","author":"R. F. Squires","year":"1993","unstructured":"Squires, R. F., and Saederup, E. 1993. Mono N-aryl ethylenediamine and piperazine derivatives are GABAA receptor blockers: implications for psychiatry. Neurochem. Res. 18:787\u2013793.","journal-title":"Neurochem. Res."},{"key":"425674_CR21","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1523\/JNEUROSCI.15-10-06957.1995","volume":"15","author":"H. L\u00fcddens","year":"1995","unstructured":"L\u00fcddens, H., and Korpi, E. R. 1995. GABA antagonists differentiate between recombinant GABAA\/benzodiazepine receptor subtypes. J. Neurosci. 15:6957\u20136962.","journal-title":"J. Neurosci."},{"key":"425674_CR22","doi-asserted-by":"crossref","first-page":"27100","DOI":"10.1016\/S0021-9258(18)47131-1","volume":"269","author":"D. Benke","year":"1994","unstructured":"Benke, D., Fritschy, J.-M., Trzeciak, A., Bannwarth, W., and Mohler, H. 1994. Distribution, prevalence, and drug binding profile of \u03b3-aminobutyric acid type A receptor subtypes differing in the \u03b2-subunit variant. J. Biol. Chem. 269:27100\u201327107.","journal-title":"J. Biol. Chem."},{"key":"425674_CR23","first-page":"59","volume":"3","author":"R. W. Olsen","year":"1990","unstructured":"Olsen, R. W., McCabe, R. T., and Wamsley, J. K. 1990. GABAA receptor subtypes: autoradiographic comparison of GABAA, benzodiazepine, and convulsant binding sites in the rat central nervous system. J. Chem. Neuroanat. 3:59\u201376.","journal-title":"J. Chem. Neuroanat."},{"key":"425674_CR24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0022-3565(25)24354-3","volume":"272","author":"I. Ducic","year":"1995","unstructured":"Ducic, I., Caruncho, H. J., Zhu, W. J., Vicini, S., and Costa, E. 1995. \u03b3-Aminobutyric acid gating of Cl\u2212 channels in recombinant GABAA receptors. J. Pharmacol. Exp. Ther. 272:438\u2013445.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"425674_CR25","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1471-4159.1985.tb08787.x","volume":"44","author":"B. A. Weissman","year":"1985","unstructured":"Weissman, B. A., Cott, J., Jackson, J. A., Bolger, G. T., Weber, K. H., Horst, W. D., Paul, S. M., and Skolnick, P. 1985. \u201cPeripheral-type\u201d binding sites for benzodiazepines in brain: Relationship to the convulsant actions of Ro 5\u20134864. J. Neurochem. 44:1494\u20131499.","journal-title":"J. Neurochem."},{"key":"425674_CR26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00172773","volume":"352","author":"E. R. Korpi","year":"1995","unstructured":"Korpi, E. R., Wong, G., and L\u00fcddens, H. 1995. Subtype specificity of \u03b3-aminobutyric acid type A receptor antagonism by clozapine. Naunyn-Schmied. Arch. Pharmacol. 352:365\u2013373.","journal-title":"Arch. Pharmacol."},{"key":"425674_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0026-895X(25)13177-5","volume":"44","author":"E. R. Korpi","year":"1993","unstructured":"Korpi E. R., and L\u00fcddens, H. 1993. Regional \u03b3-aminobutyric acid sensitivity of t-butylbicyclophosphoro[35S]thionate binding depends on \u03b3-aminobutyric acidA receptor \u03b1 subunit. Mol. Pharmacol. 44:87\u201392.","journal-title":"Mol. Pharmacol."},{"key":"425674_CR28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1176\/ajp.148.2.276","volume":"148","author":"P. J. Perry","year":"1991","unstructured":"Perry, P. J., Miller, D. D., Arndt, S. V., and Cadoret, R. J. 1991. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Amer. J. Psychiat. 148:231\u2013235.","journal-title":"Amer. J. Psychiat."},{"key":"425674_CR29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00004714-199312000-00003","volume":"13","author":"M. Hasegawa","year":"1993","unstructured":"Hasegawa, M., Gutierrez-Esteinou, R., Way, L., and Meltzer, H. Y. 1993. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking. J. Clin. Psychopharmacol. 13:383\u2013390.","journal-title":"J. Clin. Psychopharmacol."},{"key":"425674_CR30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/ajp.152.2.179","volume":"152","author":"M. H. Kronig","year":"1995","unstructured":"Kronig, M. H., Munne, R. A., Szymanski, S., Safferman, A. Z., Pollack, S., Cooper, T., Kane, J. M., and Lieberman, J. A. 1995. Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients. Amer. J. Psychiat. 152:179\u2013182.","journal-title":"Amer. J. Psychiat."},{"key":"425674_CR31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/npp.1993.50","volume":"9","author":"R. J. Baldessarini","year":"1993","unstructured":"Baldessarini, R. J., Centorrino, F., Flood, J. G., Volpicelli, S. A., Huston-Lyons, D., and Cohen, B. M. 1993. Tissue concentrations of clozapine and its metabolites in the rat. Neuropsy-chopharmacology 9:117\u2013124.","journal-title":"Neuropsy-chopharmacology"},{"key":"425674_CR32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","volume":"14","author":"F. P. Bymaster","year":"1996","unstructured":"Bymaster, F. P., Calligaro, D. O., Falcone, J. F., Marsh, R. D., Moore, N. A., Tye, N. C., Seeman, P., and Wong, D. T. 1996. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87\u201396.","journal-title":"Neuropsychopharmacology"},{"key":"425674_CR33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0306-4522(95)00357-6","volume":"70","author":"A. Y. Deutch","year":"1996","unstructured":"Deutch, A. Y., and Duman, R. S. 1996. The effects of antipsychotic drugs on fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Neuroscience 70:377\u2013389.","journal-title":"Neuroscience"},{"key":"425674_CR34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0306-4522(94)00552-G","volume":"65","author":"N. Guo","year":"1995","unstructured":"Guo, N., Klitenick, M. A., Tham, C.-S., and Fibiger, H. C. 1995. Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain. Neuroscience 65:747\u2013756.","journal-title":"Neuroscience"},{"key":"425674_CR35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1126\/science.3037702","volume":"237","author":"J. I. Morgan","year":"1987","unstructured":"Morgan, J. I., Cohen, D. R., Hempstead, J. L., and Curran, T. 1987. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237:192\u2013197.","journal-title":"Science"},{"key":"425674_CR36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0006-8993(94)01451-M","volume":"674","author":"M. C. L. Silveira","year":"1995","unstructured":"Silveira, M. C. L., Sandner, G., Di Scala, G., and Graeff, F. G. 1995. C-fos immunoreactivity in the brain following electrical or chemical stimulation of the medial hypothalamus of freely moving rats. Brain Res. 674:265\u2013274.","journal-title":"Brain Res."},{"key":"425674_CR37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0006-8993(89)90647-1","volume":"501","author":"T. Nakajima","year":"1989","unstructured":"Nakajima, T., Daval, J.-L., Morgan, P. F., Post, R. M., and Marangos, P. J. 1989. Adenosinergic modulation of caffeine-induced c-fos mRNA expression in mouse brain. Brain Res. 501:307\u2013314.","journal-title":"Brain Res."},{"key":"425674_CR38","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0306-4522(94)90288-7","volume":"59","author":"B. Johansson","year":"1994","unstructured":"Johansson, B., Lindstr\u00f6m, K., and Fredholm, B. B. 1994. Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59:837\u2013849.","journal-title":"Neuroscience"},{"key":"425674_CR39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0006-8993(91)90067-6","volume":"544","author":"M. Vendrell","year":"1991","unstructured":"Vendrell, M., Zawia, N. H., Serratosa, J., and Bondy, S. C. 1991. c-fos and ornithine decarboxylase gene expression in brain as early markers of neurotoxicity. Brain Res. 544:291\u2013296.","journal-title":"Brain Res."},{"key":"425674_CR40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-8993(95)00366-X","volume":"683","author":"J. O. Willoughby","year":"1995","unstructured":"Willoughby, J. O., Mackenzie, L., Medvedev, A., and Hiscock, J. J. 1995. Distribution of Fos-positive neurons in cortical and subcortical structures after picrotoxin-induced convulsion varies with seizure type. Brain Res. 683:73\u201387.","journal-title":"Brain Res."},{"key":"425674_CR41","doi-asserted-by":"crossref","first-page":"9569","DOI":"10.1073\/pnas.86.23.9569","volume":"86","author":"S. Ceccatelli","year":"1989","unstructured":"Ceccatelli, S., Villar, M. J., Goldstein, M., and H\u00f6kfelt, T. 1989. Expression of c-Fos immuno-reactivity in transmitter-characterized neurons after stress. Proc. Nat. Acad. Sci. 86:9569\u20139573.","journal-title":"Proc. Nat. Acad. Sci."},{"key":"425674_CR42","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1192\/bjp.168.4.516","volume":"168","author":"J. Shapleske","year":"1996","unstructured":"Shapleske, J., McKay, A. P., and McKenna, P. J. 1996. Successful treatment of tardive dystonia with clozapine and clonazepam. Brit. J. Psychiat. 168:516\u2013518.","journal-title":"Brit. J. Psychiat."},{"key":"425674_CR43","first-page":"780","volume":"151","author":"A. Klimke","year":"1994","unstructured":"Klimke, A., and Klieser, E. 1994. Sudden death after intravenous application of lorazepam in a patient treated with clozapine. Amer. J. Psychiat. 151:780.","journal-title":"Amer. J. Psychiat."},{"key":"425674_CR44","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJM199108153250716","volume":"325","author":"F. Frankenburg","year":"1991","unstructured":"Frankenburg, F., and Baldessarini, R. J. 1991. Lett. to the Editor, N. Engl. J. Med. 325:518.","journal-title":"N. Engl. J. Med."},{"key":"425674_CR45","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/266732a0","volume":"266","author":"R. F. Squires","year":"1977","unstructured":"Squires, R. F., and Braestrup, C. 1977. Benzodiazepine receptors in rat brain. Nature 266:732\u2013734.","journal-title":"Nature"},{"key":"425674_CR46","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/269702a0","volume":"269","author":"C. Braestrup","year":"1977","unstructured":"Braestrup, C., Albrechtsen, R., and Squires, R. F. 1977. High densities of benzodiazepine receptors in human cortical areas. Nature 269:702\u2013704.","journal-title":"Nature"},{"key":"425674_CR47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00427773","volume":"82","author":"S. E. File","year":"1984","unstructured":"File, S. E., Green, A. R., Nutt, D. J., and Vincent, N. D. 1984. On the convulsant action of Ro 5\u20134864 and the existence of a micromolar benzodiazepine binding site in rat brain. Psychopharmacology 82:199\u2013202.","journal-title":"Psychopharmacology"},{"key":"425674_CR48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-2999(84)90457-6","volume":"97","author":"B. A. Weissman","year":"1984","unstructured":"Weissman, B. A., Cott, J., Hommer, D., Paul, S., and Skolnick, P. 1984. Electrophysiological and pharmacological actions of the convulsant benzodiazepine Ro 5\u20134864. Eur. J. Pharmacol. 97:257\u2013263.","journal-title":"Eur. J. Pharmacol."},{"key":"425674_CR49","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1073\/pnas.86.18.7275","volume":"86","author":"G. Puia","year":"1989","unstructured":"Puia, G., Santi, M. R., Vicini, S., Pritchett, D. B., Seeburg, P. H., and Costa, E. 1989. Differences in the negative allosteric modulation of \u03b3-aminobutyric acid receptors elicited by 4\u2032-chlorodiazepam and by a \u03b2-carboline-3-carboxylate ester: A study with natural and reconstituted receptors. Proc. Natl. Acad. Sci. 86:7275\u20137279.","journal-title":"Proc. Natl. Acad. Sci."},{"key":"425674_CR50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0006-8993(84)90013-1","volume":"310","author":"J. H. Skerritt","year":"1984","unstructured":"Skerritt, J. H., Werz, M. A., McLean, M. J., and Macdonald, R. L. 1984. Diazepam and its anomalous p-Chloro-derivative Ro 5\u20134864: Comparative effects on mouse neurons in cell culture. Brain Res. 310:99\u2013105.","journal-title":"Brain Res."},{"key":"425674_CR51","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1073\/pnas.89.15.6726","volume":"89","author":"J.-M. Fritschy","year":"1992","unstructured":"Fritschy, J.-M., Benke, D., Mertens, S., Oertel, W. H., Bachi, T., and M\u00f6hler, H. 1992. Five subtypes of type A \u03b3-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies. Proc. Natl. Acad. Sci. 89:6726\u20136730.","journal-title":"Proc. Natl. Acad. Sci."},{"key":"425674_CR52","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0028-3908(81)90009-5","volume":"20","author":"P. Hunt","year":"1981","unstructured":"Hunt, P., and Clements-Jewery, S. 1981. A steroid derivative, R 5135, antagonizes the GABA\/benzodiazepine receptor interaction. Neuropharmacology 20:357\u2013361.","journal-title":"Neuropharmacology"},{"key":"425674_CR53","first-page":"383","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"R. J. Baldessarini","year":"1990","unstructured":"Baldessarini, R. J. 1990. Drugs and the treatment of psychiatric disorders. Pages 383\u2013435, in Gilman, A. G., Rall, T. W., Nies, A. S., and Taylor, P. (eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, eighth edition, Pergamon Press, New York.","edition":"eighth edition"},{"key":"425674_CR54","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/336170a0","volume":"336","author":"T. F. Freund","year":"1988","unstructured":"Freund, T. F., and Antal, M. 1988. GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus. Nature 336:170\u2013173.","journal-title":"Nature"},{"key":"425674_CR55","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1176\/ajp.138.7.913","volume":"138","author":"P. A. Berger","year":"1981","unstructured":"Berger, P. A., Watson, S. J., Akil, H., and Barchas, J. D. 1981. The effects of naloxone in chronic schizophrenia. Amer. J. Psychat. 138:913\u2013918.","journal-title":"Amer. J. Psychat."},{"key":"425674_CR56","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archpsyc.1982.04290030047009","volume":"39","author":"D. Pickar","year":"1982","unstructured":"Pickar, D., Vartanian, F., Bunney, Jr., W. E., Maier, H. P., Gastpar, M. T., Prakash, R., Sethi, B. B., Lideman, R., Belyaev, B. S., Tsutsulkovskaja, M. V. A., Jungkunz, G., Nodopil, N., Verhoeven, W., and van Praag, H. 1982. Short-term naloxone administration in schizophrenic and manic patients. Arch. Gen. Psychiat. 39:313\u2013319.","journal-title":"Arch. Gen. Psychiat."},{"key":"425674_CR57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0447.1983.tb06740.x","volume":"67","author":"D. Naber","year":"1983","unstructured":"Naber, D., M\u00fcnch, U., Wissmann, J., Grosse, R., Ritt, R., and Welter, D. 1983. Naloxone treatment for five days ineffective in schizophrenia. Acta Psychiat. Scand. 67:265\u2013271.","journal-title":"Acta Psychiat. Scand."},{"key":"425674_CR58","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.860138","volume":"196","author":"J Volavka","year":"1977","unstructured":"Volavka, J, Mallya, A., Baig, S., and Perez-Cruet, J. 1977. Naloxone in chronic schizophrenia. Science 196:1227\u20131228.","journal-title":"Science"},{"key":"425674_CR59","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0014-2999(87)90446-8","volume":"138","author":"Y. F. Jacquet","year":"1987","unstructured":"Jacquet, Y. F., Saederup, E., and Squires, R. F. 1987. Non-stereospecific excitatory actions of morphine may be due to GABA-A receptor blockade. Eur. J. Pharmacol. 138:285\u2013288.","journal-title":"Eur. J. Pharmacol."}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1027359422433.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1027359422433\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1027359422433.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T09:15:34Z","timestamp":1749719734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1027359422433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,2]]}},"alternative-id":["425674"],"URL":"https:\/\/doi.org\/10.1023\/a:1027359422433","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"type":"print","value":"0364-3190"},{"type":"electronic","value":"1573-6903"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}